The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues.
about
Interplay between protein glycosylation pathways in Alzheimer's disease.Advance directives as a tool to respect patients' values and preferences: discussion on the case of Alzheimer's disease.Paper-based electrochemiluminescence sensor for highly sensitive detection of amyloid-β oligomerization: Toward potential diagnosis of Alzheimer's disease.
P2860
The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues.
description
2017 nî lūn-bûn
@nan
2017 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues.
@ast
The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues.
@en
type
label
The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues.
@ast
The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues.
@en
prefLabel
The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues.
@ast
The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues.
@en
P2093
P50
P921
P1476
The biomarker-based diagnosis of Alzheimer's disease. 1-ethical and societal issues.
@en
P2093
Birgitta Martensson
Charles Scerri
Emiliano Albanese
Ezio Giacobini
Geneva Task Force for the Roadmap of Alzheimer's Biomarkers
Giovanni B Frisoni
Heather M Snyder
Marina Boccardi
Mark Baker
Samia Hurst
P304
P356
10.1016/J.NEUROBIOLAGING.2016.07.011
P577
2017-04-01T00:00:00Z